A-kinase anchoring protein 3 messenger RNA expression in ovarian cancer and its implication on prognosis

International Journal of Cancer

Volumn 108, Issue 1, 2004, Pages 86-90

  Hasegawa, Kosei ^a   Ono, Toshiro ^a   Matsushita, Hirokazu ^a   Shimono, Michihide ^a   Noguchi, Yuji ^a   Mizutani, Yasushi ^a   Kodama, Junichi ^a   Kudo, Takafumi ^a   Nakayama, Eiichi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

AKAP; Cancer antigen; Ovarian cancer; Prognosis

Indexed keywords

A KINASE ANCHORING PROTEIN 3; CELL PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGAR GEL ELECTROPHORESIS; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVARY; OVARY CANCER; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; CARRIER PROTEINS; CELL DIFFERENTIATION; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; OVARIAN NEOPLASMS; PROGNOSIS; RNA, MESSENGER; SURVIVAL ANALYSIS;

EID: 0345256396     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11565     Document Type: Article

References (27)

1. Pisani P, Parkin DM, Ferlay J. Estimates of the worldwide mortality from eighteen major cancers in 1985: implications for prevention and projections of future burden. Int J Cancer 1993;55:891-903.
2. Holschneider CH, Berek JS. Ovarian cancer: epidemiology, biology, prognostic factors. Semin Surg Oncol 2000;19:3-10.
3. Riman T, Persson I, Nilsson S. Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence. Clin Endocrinol 1998; 49:695-707.
4. van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, Knuth A, Boon T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991;254:1643-7.
5. Rosenberg SA. A new era for cancer immunotherapy based on the genes that encode cancer antigens. Immunity 1999;10:281-7.
6. Old LJ, Chen YT. New paths in human cancer serology. J Exp Med 1998;187:1163-7.
7. Scanlan MJ, Gordon CM, Williamson B, Lee SY, Chen YT, Stockert E, Jungbluth A, Ritter G, Jager D, Jager E, Knuth A, Old LJ. Identification of cancer/testis genes by database mining and mRNA expression analysis. Int J Cancer 2002;98:485-92.
8. Michel JJ, Scott JD. AKAP mediated signal transduction. Annu Rev Pharmacol 2002;42:235-57.
9. Indolfi C, Stabile E, Coppola C, Gallo A, Perrino C, Allevato G, Cavuto L, Torella D, Di Lorenzo E, Troncone G, Feliciello A, Avvedimento E, et al. Membrane-bound protein kinase A inhibits smooth muscle cell proliferation in vitro and in vivo by amplifying cAMP-protein kinase A signals. Circulation Res 2001;88:319-24.
10. Williams RO. A-kinase anchor proteins are involved in maintaining resting T cells in an inactive state. J Immunol 2002;168:5392-6.
11. Schillace R, Vrews S. F, Liberty GA, Davey MP, Carr DW. Identification and characterization, of myeloid translocation gene 16b as a novel a kinase anchoring protein in T lymphocytes. J Immunol 2002;168:1590-9.
12. Srivastava RK, Srivastava AR, Korsmeyer SJ, Nesterova M, Cho-Chung YS, Longo DL. Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Mol Cell Biol 1998;18:3509-17.
13. Tortora G, di Isernia G, Sandomenico C, Bianco R, Pomatico G, Pepe S, Bianco AR, Ciardiello F. Synergistic inhibition of growth and induction of apoptosis by 8-chloro-cAMP and paclitaxel or cisplatin in human cancer cells. Cancer Res 1997;57:5107-11.
14. Covens A, Carey M, Bryson P, Verma S, Fung Kee Fung M, Johnston M. Systematic review of first-line chemotherapy for newly diagnosed postoperative patients with stage II, III, or IV epithelial ovarian cancer. Gynecol Oncol 2002;85:71-80.
15. Young M, Plosker GL. Paclitaxel: a pharmacoeconomic review of its use in the treatment of ovarian cancer. Pharmacoeconomics 2001;19: 1227-59.
16. Vijayaraghavan S, Liberty GA, Mohan J, Winfrey VP, Olson GE, Carr DW. Isolation and molecular characterization of AKAP110, a novel, sperm-specific protein kinase A-anchoring protein. Mol Endocrinol 1999;13:705-17.
17. Kurashige T, Noguchi Y, Saika T, Ono T, Nagata Y, Jungbluth A, Ritter G, Chen YT, Stockert E, Tsushima T, Kumon H, Old LJ, et al. NY-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor grade. Cancer Res 2001; 61:4671-4.
18. Brasseur F, Rimoldi D, Lienard D, Lethe B, Carrel S, Arienti F, Suter L, Vanwijck R, Bourlond A, Humblet Y. Expression of MAGE genes in primary and metastatic cutaneous melanoma. Int J Cancer 1995; 63:375-80.
19. Akatsuka T, Wada T, Kokai Y, Kawaguchi S, Isu K, Yamashiro K, Yamashita T, Sawada N, Yamawaki S, Ishii S. ErbB2 expression is correlated with increased survival of patients with osteosarcoma. Cancer 2002;94:1397-404.
20. Colledge M, Scott JD. AKAPs: from structure to function. Trends Cell Biol 1999;9:216-21.
21. Feliciello A, Gottesman ME, Avvedimento EV. The biological functions of A-kinase anchor proteins. J Mol Biol 2001;308:99-114.
22. Indolfi C, Avvedimento EV, Di Lorenzo E, Esposito G, Rapacciuolo A, Giuliano P, Grieco D, Cavuto L, Stingone AM, Ciullo I, Condorelli G, Chiariello M. Activation of cAMP-PKA signaling in vivo inhibits smooth muscle cell proliferation induced by vascular injury. Nat Med 1997;3:775-9.
23. Kim SN, Ahn YH, Kim SG, Park SD, Cho-Chung YS, Hong SH. 8-Cl-cAMP induces cell cycle-specific apoptosis in human cancer cells. Int J Cancer 2001;93:33-41.
24. Cho YS, Kim MK, Tan L, Srivastava R, Agrawal S, Cho-Chung YS. Protein kinase A Rlalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, Bad-hypophosphorylation. Clin Cancer Res 2002;8:607-614.
25. Srivastava RK, Srivastava, AR, Cho-Chung, YS, Longo DL. Synergistic effects of retinoic acid and 8-Cl-cAMP on apoptosis require caspase-3 activation in human ovarian cancer cells. Oncogene 1999; 18:1755-63.
26. Shaw TJ, Keszthelyi EJ, Tonary AM, Cada M, Vanderhyden BC. Cyclic AMP in ovarian cancer cells both inhibits proliferation and increases c-KIT expression. Exp Cell Res 2002;273:95-106.
27. Yan L, Herrmann V, Hofer JK, Insel PA. beta-adrenergic receptor/cAMP-mediated signaling and apoptosis of S49 lymphoma cells. Am J Physiol Cell Physiol 2000;279:1665-74.